Novo Nordisk Begins Study of Lexicon Oral Obesity Drug

Group 1 - The study is focused on investigating the safety and tolerability of LX9851 [1] - The research examines how LX9851 moves through the body [1] - The physiological and biological impacts of LX9851 are being assessed [1]